NYSE · Drug Manufacturers - Specialty & Generic

ELAN (ELAN) Stock

$25.69 -2.58% NYSE: ELAN Healthcare

Valuation

MetricValue
Price$25.69
Market Cap$12.83B
P/E Ratio-42.77
P/B Ratio1.53
P/S Ratio2.02
EPS (TTM)$-0.47
52-Week High$27.72
52-Week Low$13.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.54%
ROA-1.74%
ROCE3.85%
Gross Margin5.34%
Operating Margin5.34%
Net Margin-4.95%
Debt/Equity0.61
Current Ratio2.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.8B$4.4B$4.4B$4.4B$4.7B
Operating Profit$304.0M$384.0M$326.0M$251.0M$252.0M
Net Profit$-483.0M$-78.0M$-1.2B$338.0M$-232.0M
EPS$-0.97$-0.15$-2.50$0.68$-0.47
Op Margin6.4%8.7%7.4%5.7%5.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$16.5B$15.5B$14.4B$12.6B$13.4B
Total Liabilities$9.0B$8.2B$8.1B$6.5B$6.8B
Cash$638.0M$345.0M$352.0M$468.0M$545.0M
Borrowings$6.3B$5.8B$5.8B$4.3B$4.0B

Latest News

National Advertising Division Finds Certain PetIQ Claims Supported; Recommends Other Comparative Claims Be Modified or Discontinued GlobeNewswire · Jul 16, 2026 Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 15, 2026 Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement PR Newswire · Jul 8, 2026 Is the Options Market Predicting a Spike in Elanco Animal Health Stock? Zacks · Jun 30, 2026 Is Elanco Animal Health Incorporated (ELAN) Positioned for Long-Term Growth With Seven Potential Blockbuster Launches? Insider Monkey · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$483.0M$452.0M$271.0M$541.0M$560.0M
Investing Cash Flow$-727.0M$-363.0M$-323.0M$1.0B$-555.0M
Financing Cash Flow$33.0M$-32.0M$-6.0M$-17.0M$288.0M
Net Cash Flow$132.0M$-293.0M$7.0M$116.0M$77.0M
Free Cash Flow$286.0M$268.0M$117.0M$394.0M$284.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA14.49
FCF Yield3.19%
Quick Ratio1.12
Interest Coverage1.15
Return 1Y73.57%
Return 3Y111.98%
Return 5Y-29.28%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALGNAlign Technology, Inc. $169.29 +1.36% 27.86 $12.12B 0.00%
EHC $116.68 +2.45% 18.97 $11.57B 0.71%
ENSG $181.35 +1.84% 25.83 $10.60B 0.16%
NBIXNeurocrine Biosciences, Inc. $182.83 +3.64% 23.97 $18.38B 0.00%
QGEN $42.28 +2.92% 16.78 $8.72B 0.73%

About ELAN

ELAN is led by CEO Jeffrey N. Simmons, employs 9,900 people, headquartered in Indianapolis, US, publicly traded since 2018.

ELAN stock trades at $25.69 with a market capitalization of $12.83B. The stock is valued at a price-to-earnings (P/E) ratio of -42.77, price-to-book of 1.53, price-to-sales of 2.02. Over the past 52 weeks the stock has ranged between $13.16 and $27.72, and currently trades 7.3% below its 52-week high.

On profitability, ELAN generates a return on equity (ROE) of -3.54%, return on capital employed of 3.85%, an operating margin of 5.34%, a net profit margin of -4.95%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides